Results
74,196 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 21 | Ridloff ElenaCFO and CBO |  SIONSionna Therapeutics, Inc.Grant or award | A | — 47.3K sh | Sep 18, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 21 | Ridloff ElenaCFO and CBO | SIONSionna Therapeutics, Inc. Grant or award | A | — 47.3K sh | Sep 18, 2026 |
| 21 | Ridloff ElenaCFO and CBO | SIONSionna Therapeutics, Inc. Grant or award | A | — 47.3K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 21 | Lumpkin AlexandraChief Legal Officer |  REAXReal REMAX Group Inc.Option exercise | M | — 302 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 21 | McKee CharlotteCMO and Head of R&D | SIONSionna Therapeutics, Inc. Grant or award | A | — 50.0K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 21 | Fuchs ThomasDirector |  WGSGeneDx Holdings Corp.Option exercise | M | — 1,146 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 21 | McKee CharlotteCMO and Head of R&D | SIONSionna Therapeutics, Inc. Grant or award | A | — 50.0K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 21 | Blackburn Jeffrey MDirector |  STUBStubHub Holdings, Inc.Grant or award | A | — 42.4K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 21 | Stetter MarkDirector |  ZTSZoetis Inc.Grant or award | A | $25K 342 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 21 | Epperly Melissa B,Director |  ROIVRoivant Sciences Ltd.Grant or award | A | — 5,054 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | Dumont Robert LouisDirector |  SCHLSCHOLASTIC CORPGrant or award | A | $130K 3,700 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | Cislini JeffSVP & General Counsel |  RVMDRevolution Medicines, Inc.Open-market sale · 10b5-1 plan | SELL | $10K 52 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | Li LindaDirector | SCHLSCHOLASTIC CORP Grant or award | A | $130K 3,700 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | Walker VerdellDirector | SCHLSCHOLASTIC CORP Grant or award | A | $130K 3,700 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | von Ahn LuisDirector, President & CEO, Co-Founder, 10% Owner |  DUOLDuolingo, Inc.Open-market sale · 10b5-1 plan | SELL | $155K 1,020 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | Kleiser Kirk E.Director |  CLSTCatalyst Bancorp, Inc.Option exercise | M | $225K 16.9K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | Budur KumarCHIEF MEDICAL OFFICER |  HRMYHarmony Biosciences Holdings, Inc.Option exercise | M | $770K 25.4K sh | Sep 18, 2026 traded Sep 18, 2026 |
| 20 | Budur KumarCHIEF MEDICAL OFFICER | HRMYHarmony Biosciences Holdings, Inc. Option exercise | M | $319K 10.4K sh | Sep 18, 2026 traded Sep 18, 2026 |
| 20 | Sandler Alan B.Chief Development Officer | RVMDRevolution Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $975 5 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | Henderson KayaDirector | SCHLSCHOLASTIC CORP Grant or award | A | $130K 3,700 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | Guerrier AlixDirector | SCHLSCHOLASTIC CORP Grant or award | A | $130K 3,700 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | Anders JackChief Financial Officer | RVMDRevolution Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $12K 61 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 19 | Okupe OluyemiChief Financial Officer |  HIMSHims & Hers Health, Inc.Open-market sale · 10b5-1 plan | SELL | $355K 12.3K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 19 | Feeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $4,961 52 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 19 | Sousa Mauad BrunoDirector |  AUGOAura Minerals Inc.Derivative conversion | C | $1.53M 17.2K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 19 | Baer MattDirector, Chief Executive Officer |  SFIXStitch Fix, Inc.Tax withholding | F | $338K 115.1K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 18 | Lo FrancisChief People Officer |  ADPTAdaptive Biotechnologies CorpOpen-market sale · 10b5-1 plan | SELL | $3.01M 107.5K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 17 | Allen William TDirector |  SVVSavers Value Village, Inc.Option exercise | M | $17K 12.4K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 17 | Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER | WGSGeneDx Holdings Corp. Option exercise | M | — 18.8K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 17 | Furner John R.Director, President & CEO |  WMTWalmart Inc.Open-market sale · 10b5-1 plan | SELL | $754K 7,080 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 17 | Rozenblat JennaPresident | REAXReal REMAX Group Inc. Option exercise | M | — 417 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 17 | Fitzpatrick JenniferCLO and Head of Program Mgmt. | SIONSionna Therapeutics, Inc. Grant or award | A | — 28.1K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 17 | Rozenblat JennaPresident | REAXReal REMAX Group Inc. Disposition to issuer | D | — 333 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 17 | Allen William TDirector | SVVSavers Value Village, Inc. Option exercise | M | $17K 12.4K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 17 | Furner John R.Director, President & CEO | WMTWalmart Inc. Open-market sale · 10b5-1 plan | SELL | $646K 6,045 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 16 | Frisby Jeffry DDirector |  ATROASTRONICS CORPOption exercise | M | $95K 4,000 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 16 | Lin LaurenCLO, CCO and Secretary |  WLTHWEALTHFRONT CORPOpen-market sale · 10b5-1 plan | SELL | $46K 4,574 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 16 | Polovin AndrewEVP, Chief Legal Officer |  TEMTempus AI, Inc.Open-market sale · 10b5-1 plan | SELL | $221K 2,951 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 16 | Wang LingkeDirector, President |  LIFEEthos Technologies Inc.Open-market sale · 10b5-1 plan | SELL | $4.31M 110.6K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 16 | Mancini AnthonySee Remarks | RVMDRevolution Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $5,266 27 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 15 | Blackman DonnaCHIEF FINANCIAL OFFICER |  LRNStride, Inc.Tax withholding | F | $718K 8,747 sh | Sep 18, 2026 traded Sep 16, 2026 |